Track topics on Twitter Track topics that are important to you
President Donald J. Trump has nominated Alex Azar II, the head of pharmaceutical company Eli Lilly’s U.S.-based operations until this past January, to be his next HHS secretary, as reported by The New York Times.
Reports indicate that if confirmed, Azar would play a critical role in implementing the president’s efforts to crack down on drug prices in the U.S and the administration’s initiatives to repeal and replace the Affordable Care Act.
At least one Democrat was quick to criticize the nomination.
“President Trump has railed against the pharmaceutical industry ‘getting
Original Article: Trump nominates former pharmaceutical executive for HHS secretaryNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...